Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Glenda E. Gray, Fatima Laher, Tanya Doherty, Salim Abdool Karim, Scott Hammer, John Mascola, Christopher Beyrer, Larry Corey

Research output: Contribution to journalArticle

Abstract

In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date—a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.

Original languageEnglish (US)
Article numbere1002372
JournalPLoS Biology
Volume14
Issue number3
DOIs
StatePublished - Mar 2 2016

Fingerprint

Biomedical Technology
Acquired Immunodeficiency Syndrome
Vaccines
Health
HIV
biomedical research
HIV infections
HIV Infections
Biomedical Research
vaccines
therapeutics
Therapeutics
Infection
infection

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Gray, G. E., Laher, F., Doherty, T., Abdool Karim, S., Hammer, S., Mascola, J., ... Corey, L. (2016). Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? PLoS Biology, 14(3), [e1002372]. https://doi.org/10.1371/journal.pbio.1002372

Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? / Gray, Glenda E.; Laher, Fatima; Doherty, Tanya; Abdool Karim, Salim; Hammer, Scott; Mascola, John; Beyrer, Christopher; Corey, Larry.

In: PLoS Biology, Vol. 14, No. 3, e1002372, 02.03.2016.

Research output: Contribution to journalArticle

Gray, GE, Laher, F, Doherty, T, Abdool Karim, S, Hammer, S, Mascola, J, Beyrer, C & Corey, L 2016, 'Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?', PLoS Biology, vol. 14, no. 3, e1002372. https://doi.org/10.1371/journal.pbio.1002372
Gray GE, Laher F, Doherty T, Abdool Karim S, Hammer S, Mascola J et al. Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? PLoS Biology. 2016 Mar 2;14(3). e1002372. https://doi.org/10.1371/journal.pbio.1002372
Gray, Glenda E. ; Laher, Fatima ; Doherty, Tanya ; Abdool Karim, Salim ; Hammer, Scott ; Mascola, John ; Beyrer, Christopher ; Corey, Larry. / Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?. In: PLoS Biology. 2016 ; Vol. 14, No. 3.
@article{7b8ad4e1760e421e8647aa2bbe1a1210,
title = "Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?",
abstract = "In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date—a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.",
author = "Gray, {Glenda E.} and Fatima Laher and Tanya Doherty and {Abdool Karim}, Salim and Scott Hammer and John Mascola and Christopher Beyrer and Larry Corey",
year = "2016",
month = "3",
day = "2",
doi = "10.1371/journal.pbio.1002372",
language = "English (US)",
volume = "14",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

AU - Gray, Glenda E.

AU - Laher, Fatima

AU - Doherty, Tanya

AU - Abdool Karim, Salim

AU - Hammer, Scott

AU - Mascola, John

AU - Beyrer, Christopher

AU - Corey, Larry

PY - 2016/3/2

Y1 - 2016/3/2

N2 - In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date—a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.

AB - In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful life-saving development of medical research. Antiretrovirals (ARVs) are used with great success for both the treatment and prevention of HIV infection. Despite these remarkable advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur each year, two-thirds in women and 240,000 in children. The widespread elimination of HIV will require the development of new, more potent prevention tools. Such efforts are imperative on a global scale. However, it must also be recognised that true containment of the epidemic requires the development and widespread implementation of a scientific advancement that has eluded us to date—a highly effective vaccine. Striving for such medical advances is what is required to achieve the end of AIDS.

UR - http://www.scopus.com/inward/record.url?scp=84962147311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962147311&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.1002372

DO - 10.1371/journal.pbio.1002372

M3 - Article

C2 - 26933962

AN - SCOPUS:84962147311

VL - 14

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 3

M1 - e1002372

ER -